The innovative drug concept fluctuated and increased. Guilin Sanjin went up and down, while Laimei Pharmaceutical, CSPC Innovation, Yifang Bio-U, BeiGene Shenzhou, Nuocheng Jianhua, and Tylomaebe-U followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.